Clinical Trial: An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07197866) titled 'An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy' on Sept. 26.

Brief Summary: The primary objective of the trial is to describe the long-term safety and tolerability of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA).

A secondary objective of the trial is to further describe the safety and tolerability of TEV-56286.

The planned total duration of the trial is approximately 100 weeks.

Study Start Date: Sept. 29

Study Type: INTERVENTIONAL

Condition: Multiple System Atrophy

Intervention: DRUG: TEV-56286

administered orally

Recrui...